Sleep apnea treatment changed by weight loss drug Zepbound at Long Island clinics | NYGazet

The approval marked another step in the increasingly popular, and pricey, use of GLP-1 medications.

Long Islanders suffering from sleep apnea inundated the sleep center at St. Charles Hospital in Port Jefferson with phone calls earlier this year after the Food and Drug Administration approved Zepbound, one of the new weight loss medications, as the... [7982 chars]